{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-030829","form_type":"8-K","ticker":"CTXR","cik":"0001506251","company_name":"Citius Pharmaceuticals, Inc.","filed_at":"2024-04-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.723423+00:00","generated_at":"2026-06-04T01:47:22.460303+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Citius extends CEO/EVP warrants to April 5, 2025; exercise would yield $2.3M","bullets":["Board approved one-year extension for 1,294,498 Investor Warrants held by CEO Leonard Mazur and EVP Myron Holubiak, exercise price $1.42 each.","Also extended 240,130 Placement Agent Warrants held by H.C. Wainwright representatives, exercise price $1.9313 per share.","Warrants were originally issued in April 2019 and previously extended to April 2024; no other warrants from that offering remain.","Full exercise of all extended warrants would generate about $2.3 million in cash proceeds for the company.","All other terms and conditions of the warrants remain unchanged."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-030829","json":"https://secwatch.observer/filing/0001213900-24-030829.json","markdown":"https://secwatch.observer/filing/0001213900-24-030829.md","text":"https://secwatch.observer/filing/0001213900-24-030829.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1506251/000121390024030829/0001213900-24-030829-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1506251/000121390024030829/ea0203367-8k_citius.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T01:47:22.460303+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}